Manufacturer record
Aprazer Healthcare Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Aprazer Healthcare Pvt. Ltd (Himachal Pradesh) was declared Not of Standard Quality in June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ACC2502LV, Lenvatinib Capsules IP 4 mg (exp Apr 2027). CDL Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform toI.P. with respect to the test for Identification Lenvatinib mesylate eq. to Lenvatinib. Listed in the June 2026 alert.
Records by type
1 record linked to Aprazer Healthcare Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Lenvatinib Capsules IP 4 mg | Batch ACC2502LVMfg May 2025 · Exp Apr 2027 | The sample does not conform toI.P. with respect to the test for Identification Lenvatinib mesylate eq. to Lenvatinib.Identification | CDL KolkataCDSCO lab | Jun 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.